150 related articles for article (PubMed ID: 38072363)
1. Degenerated Transcatheter Aortic Valve Replacement: Investigation and Management Options.
Mauler-Wittwer S; Giannakopoulos G; Arcens M; Noble S
Can J Cardiol; 2024 Feb; 40(2):300-312. PubMed ID: 38072363
[TBL] [Abstract][Full Text] [Related]
2. Redo transcatheter aortic valve replacement in degenerated transcatheter bioprosthesis (TAV-in-TAV).
Sánchez-Ceña J; Asmarats L; Li CHP; Millán X; Fernández-Peregrina E; Menduiña I; Massó van Roessel A; Arzamendi D
Expert Rev Cardiovasc Ther; 2023; 21(10):703-712. PubMed ID: 37815845
[TBL] [Abstract][Full Text] [Related]
3. Transcatheter Aortic Valve Replacement in Failed Transcatheter Bioprosthetic Valves.
Tarantini G; Sathananthan J; Fabris T; Landes U; Bapat VN; Khan JM; Nai Fovino L; Zaid S; Van Mieghem NM; Latib A; Waksman R; De Backer O; Rogers T; Søndergaard L; Tang GHL
JACC Cardiovasc Interv; 2022 Sep; 15(18):1777-1793. PubMed ID: 36137681
[TBL] [Abstract][Full Text] [Related]
4. Challenges and Future Directions in Redo Aortic Valve Reintervention After Transcatheter Aortic Valve Replacement Failure.
Zaid S; Bapat VN; Sathananthan J; Landes U; De Backer O; Tarantini G; Grubb KJ; Kaneko T; Khalique OK; Jilaihawi H; Fukui M; Madhavan M; Cangut B; Harrington K; Thourani VH; Makkar RR; Leon MB; Mack MJ; Tang GHL
Circ Cardiovasc Interv; 2023 Nov; 16(11):e012966. PubMed ID: 37988437
[TBL] [Abstract][Full Text] [Related]
5. A systematic review on durability and structural valve deterioration in TAVR and surgical AVR.
Okutucu S; Niazi AK; Oliveira D; Fatihoglu SG; Oto A
Acta Cardiol; 2021 Nov; 76(9):921-932. PubMed ID: 33302806
[TBL] [Abstract][Full Text] [Related]
6. Transcatheter aortic valve replacement for structural degeneration of previously implanted transcatheter valves (TAVR-in-TAVR): a systematic review.
Gallo M; Fovino LN; Blitzer D; Doulamis IP; Guariento A; Salvador L; Tagliari AP; Ferrari E
Eur J Cardiothorac Surg; 2022 May; 61(5):967-976. PubMed ID: 34662376
[TBL] [Abstract][Full Text] [Related]
7. Valve-in-valve transcatheter aortic valve replacement versus redo aortic valve replacement: which procedure for which patient?
Hutt E; Mehra N; Desai MY
Expert Rev Cardiovasc Ther; 2022 Dec; 20(12):911-918. PubMed ID: 36433699
[TBL] [Abstract][Full Text] [Related]
8. Explant vs Redo-TAVR After Transcatheter Valve Failure: Mid-Term Outcomes From the EXPLANTORREDO-TAVR International Registry.
Tang GHL; Zaid S; Kleiman NS; Goel SS; Fukuhara S; Marin-Cuartas M; Kiefer P; Abdel-Wahab M; De Backer O; Søndergaard L; Saha S; Hagl C; Wyler von Ballmoos M; Bhadra O; Conradi L; Grubb KJ; Shih E; DiMaio JM; Szerlip M; Vitanova K; Ruge H; Unbehaun A; Kempfert J; Pirelli L; Kliger CA; Van Mieghem N; Hokken TW; Adrichem R; Modine T; Corona S; Wang L; Petrossian G; Robinson N; Meier D; Webb JG; Cheung A; Ramlawi B; Herrmann HC; Desai ND; Andreas M; Mach M; Waksman R; Schults CC; Ahmad H; Goldberg JB; Geirsson A; Forrest JK; Denti P; Belluschi I; Ben-Ali W; Asgar AW; Taramasso M; Rovin JD; Di Eusanio M; Colli A; Kaneko T; Nazif TN; Leon MB; Bapat VN; Mack MJ; Reardon MJ; Sathananthan J
JACC Cardiovasc Interv; 2023 Apr; 16(8):927-941. PubMed ID: 37100556
[TBL] [Abstract][Full Text] [Related]
9. Valve-in-valve transcatheter aortic valve replacement versus redo surgical aortic valve replacement: A systematic review and meta-analysis.
Ahmed A; Levy KH
J Card Surg; 2021 Jul; 36(7):2486-2495. PubMed ID: 33797799
[TBL] [Abstract][Full Text] [Related]
10. The BASILICA Trial: Prospective Multicenter Investigation of Intentional Leaflet Laceration to Prevent TAVR Coronary Obstruction.
Khan JM; Greenbaum AB; Babaliaros VC; Rogers T; Eng MH; Paone G; Leshnower BG; Reisman M; Satler L; Waksman R; Chen MY; Stine AM; Tian X; Dvir D; Lederman RJ
JACC Cardiovasc Interv; 2019 Jul; 12(13):1240-1252. PubMed ID: 31202947
[TBL] [Abstract][Full Text] [Related]
11. Two-Year Outcomes of Valve-in-Valve Using New-Generation Transcatheter Devices Compared With Redo-SAVR.
Nagasaka T; Koren O; Patel V; Naami R; Naami E; Shechter A; Kohan S; Allison Z; Lerner A; Cheng DE; Chakravarty T; Cheng W; Jilaihawi H; Ishii H; Nakamura M; Makkar RR
Am J Cardiol; 2023 Nov; 207():380-389. PubMed ID: 37778227
[TBL] [Abstract][Full Text] [Related]
12. Redo-TAVR Feasibility After SAPIEN 3 Stratified by Implant Depth and Commissural Alignment: A CT Simulation Study.
Koshy AN; Tang GHL; Khera S; Vinayak M; Berdan M; Gudibendi S; Hooda A; Safi L; Lerakis S; Dangas GD; Sharma SK; Kini AS; Krishnamoorthy P
Circ Cardiovasc Interv; 2024 Mar; 17(3):e013766. PubMed ID: 38502723
[TBL] [Abstract][Full Text] [Related]
13. Meta-analysis comparing valve-in-valve TAVR and redo-SAVR in patients with degenerated bioprosthetic aortic valve.
Saleem S; Ullah W; Syed MA; Megaly M; Thalambedu N; Younas S; Zahid S; Alam M; Virani SS; Verma DR; Abdul-Waheed M; Fischman DL
Catheter Cardiovasc Interv; 2021 Nov; 98(5):940-947. PubMed ID: 34110684
[TBL] [Abstract][Full Text] [Related]
14. Durability of Transcatheter and Surgical Bioprosthetic Aortic Valves in Patients at Lower Surgical Risk.
Søndergaard L; Ihlemann N; Capodanno D; Jørgensen TH; Nissen H; Kjeldsen BJ; Chang Y; Steinbrüchel DA; Olsen PS; Petronio AS; Thyregod HGH
J Am Coll Cardiol; 2019 Feb; 73(5):546-553. PubMed ID: 30732707
[TBL] [Abstract][Full Text] [Related]
15. A comparison of valve-in-valve transcatheter aortic valve replacement in failed stentless versus stented surgical bioprosthetic aortic valves.
Choi CH; Cheng V; Malaver D; Kon N; Kincaid EH; Gandhi SK; Applegate RJ; Zhao DXM
Catheter Cardiovasc Interv; 2019 May; 93(6):1106-1115. PubMed ID: 30588736
[TBL] [Abstract][Full Text] [Related]
16. Hemodynamic Outcome and Valve Durability Beyond Five Years After Transcatheter Aortic Valve Replacement.
Murray MI; Hofmann E; De Rosa R; Mas-Peiro S; Seppelt P; Walther T; Zeiher AM; Fichtlscherer S; Vasa-Nicotera M
J Invasive Cardiol; 2020 Mar; 32(3):82-87. PubMed ID: 32123140
[TBL] [Abstract][Full Text] [Related]
17. Repeat Transcatheter Aortic Valve Replacement for Transcatheter Prosthesis Dysfunction.
Landes U; Webb JG; De Backer O; Sondergaard L; Abdel-Wahab M; Crusius L; Kim WK; Hamm C; Buzzatti N; Montorfano M; Ludwig S; Schofer N; Voigtlaender L; Guerrero M; El Sabbagh A; Rodés-Cabau J; Guimaraes L; Kornowski R; Codner P; Okuno T; Pilgrim T; Fiorina C; Colombo A; Mangieri A; Eltchaninoff H; Nombela-Franco L; Van Wiechen MPH; Van Mieghem NM; Tchétché D; Schoels WH; Kullmer M; Tamburino C; Sinning JM; Al-Kassou B; Perlman GY; Danenberg H; Ielasi A; Fraccaro C; Tarantini G; De Marco F; Witberg G; Redwood SR; Lisko JC; Babaliaros VC; Laine M; Nerla R; Castriota F; Finkelstein A; Loewenstein I; Eitan A; Jaffe R; Ruile P; Neumann FJ; Piazza N; Alosaimi H; Sievert H; Sievert K; Russo M; Andreas M; Bunc M; Latib A; Govdfrey R; Hildick-Smith D; Sathananthan J; Hensey M; Alkhodair A; Blanke P; Leipsic J; Wood DA; Nazif TM; Kodali S; Leon MB; Barbanti M
J Am Coll Cardiol; 2020 Apr; 75(16):1882-1893. PubMed ID: 32327098
[TBL] [Abstract][Full Text] [Related]
18. Transcatheter valve-in-valve versus redo surgical aortic valve replacement for the treatment of degenerated bioprosthetic aortic valve: A systematic review and meta-analysis.
Tam DY; Vo TX; Wijeysundera HC; Dvir D; Friedrich JO; Fremes SE
Catheter Cardiovasc Interv; 2018 Dec; 92(7):1404-1411. PubMed ID: 30024102
[TBL] [Abstract][Full Text] [Related]
19. Transcatheter Aortic Valve-in-Valve Procedure in Patients with Bioprosthetic Structural Valve Deterioration.
Reul RM; Ramchandani MK; Reardon MJ
Methodist Debakey Cardiovasc J; 2017; 13(3):132-141. PubMed ID: 29743998
[TBL] [Abstract][Full Text] [Related]
20. Lifetime management for aortic stenosis: Planning for future therapies.
Basman C; Pirelli L; Singh VP; Reimers CD; Hemli J; Brinster DR; Patel NC; Scheinerman SJ; Kliger CA
J Cardiol; 2022 Sep; 80(3):185-189. PubMed ID: 35016808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
